Medical Cannabis Patients Are Widely Using Minor Cannabinoids Like CBG, CBN, and Delta-8

A survey of 1,721 medical cannabis patients found widespread use of minor cannabinoids including delta-8 THC, THCA, CBG, and CBN, with many patients substituting cannabis for prescription medications.

Cuttler, Carrie et al.·Journal of psychoactive drugs·2025·Moderate EvidenceCross-Sectional
RTHC-06281Cross SectionalModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

The most commonly used cannabinoids were CBD, delta-9 THC, delta-8 THC, and THCA. The majority reported stopping one or more pharmaceutical medications because of their medical cannabis use.

Key Numbers

1,721 medical cannabis patients surveyed. Most common methods: smoking flower, vape pen/cartridge, edibles. Majority stopped one or more pharmaceuticals.

How They Did This

Survey of 1,721 US medical cannabis patients assessing patterns of use and motivations across a wide variety of cannabinoid products.

Why This Research Matters

The cannabinoid marketplace has expanded dramatically, but research and regulation have not kept pace.

The Bigger Picture

Patients are making treatment decisions about compounds like CBG, CBN, and delta-8 THC with very limited clinical data.

What This Study Doesn't Tell Us

Self-selected sample. Self-reported data. No verification of medications discontinued or clinical outcomes.

Questions This Raises

  • ?Are patients achieving better outcomes with minor cannabinoids?
  • ?What are the safety profiles of daily CBG, CBN, or THCA use?

Trust & Context

Key Stat:
Majority of 1,721 medical cannabis patients stopped at least one pharmaceutical after starting cannabis
Evidence Grade:
Large survey with broad cannabinoid coverage; moderate because of sample size despite self-selection.
Study Age:
2025 study capturing current cannabinoid market trends
Original Title:
Minor Cannabinoid Use Among Medical Cannabis Patients.
Published In:
Journal of psychoactive drugs, 1-10 (2025)
Database ID:
RTHC-06281

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

What are minor cannabinoids?

Compounds found in cannabis in smaller quantities than THC and CBD. They include CBG, CBN, THCA, delta-8 THC, and others.

Is it safe to stop prescription medications and use cannabis instead?

This study did not evaluate whether it was medically appropriate. Stopping prescription medications without medical guidance can be dangerous.

Read More on RethinkTHC

Cite This Study

RTHC-06281·https://rethinkthc.com/research/RTHC-06281

APA

Cuttler, Carrie; Boehnke, Kevin F; Doucette, Mitchell L; Wilson-Poe, Adrianne R; Kruger, Daniel J. (2025). Minor Cannabinoid Use Among Medical Cannabis Patients.. Journal of psychoactive drugs, 1-10. https://doi.org/10.1080/02791072.2025.2607725

MLA

Cuttler, Carrie, et al. "Minor Cannabinoid Use Among Medical Cannabis Patients.." Journal of psychoactive drugs, 2025. https://doi.org/10.1080/02791072.2025.2607725

RethinkTHC

RethinkTHC Research Database. "Minor Cannabinoid Use Among Medical Cannabis Patients." RTHC-06281. Retrieved from https://rethinkthc.com/research/cuttler-2025-minor-cannabinoid-use-among

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.